Your browser doesn't support javascript.
loading
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor.
Katz, R B; Toprak, M; Wilkinson, S T; Sanacora, G; Ostroff, R.
Afiliación
  • Katz RB; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA. Electronic address: Rachel.katz@yale.edu.
  • Toprak M; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
  • Wilkinson ST; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
  • Sanacora G; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
  • Ostroff R; Yale Department of Psychiatry, Yale School of Medicine, 184 Liberty Street, New Haven, CT, USA.
Gen Hosp Psychiatry ; 54: 62-64, 2018.
Article en En | MEDLINE | ID: mdl-30100209
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Ketamina / Inhibidores de la Monoaminooxidasa / Antidepresivos Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gen Hosp Psychiatry Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Ketamina / Inhibidores de la Monoaminooxidasa / Antidepresivos Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Gen Hosp Psychiatry Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos